Blog
Buffett Still Loves Occidental, but Here's Monday's Mammoth Market Mover
The stock market got a big boost of confidence last week, as investors seemed to get more comfortable with the likely future course of monetary policy. Although most market participants expect the
Better Buy: American Eagle Outfitters vs. Abercrombie & Fitch
American Eagle Outfitters (NYSE: AEO) and Abercrombie & Fitch (NYSE: ANF) both recently disappointed investors with dismal quarterly earnings reports and soft guidance for the rest of the year
Costco Stock: Prime Time to Buy Now?
Stock market corrections are normal, so investors are searching for safe stocks to buy today. The global economic backdrop is more uncertain than it has been in a long time with generation-high
Better Buy: Advanced Micro Devices vs. Nvidia
Tech stocks have been hit hard in 2022, with the NASDAQ-100 Technology Sector index down 33% year to date. Multiple companies have taken significant hits to their stocks, with Nvidia (NASDAQ: NVDA)
The Next Bull Market Is Coming: 2 Growth Stocks Down 68% and 74% to Buy Now
It has been a tough year for investors. The tech-heavy Nasdaq Composite is currently 24% off its high, putting the index in bear market territory, and many individual stocks have fallen even
This Stock Has Delivered a Gain of 100% Over the Past 3 Months. Can You Still Buy?
Amylyx Pharmaceuticals (NASDAQ: AMLX) is up more than 100% over the past three months. The stock surged again on Sept. 7 after a Food and Drug Administration (FDA) advisory panel changed their minds
Why Tuesday Could Be a Huge Day for the Stock Market
The stock market has been a fickle place in 2022, with investor sentiment constantly changing by the day, week, and month. Inflation, which has been hovering near a 40-year high, has become the
AMC Is in a "Very Different Situation" Than Bankrupt Regal? Not So Fast.
Regal Cinemas parent Cineworld Group (OTC: CNNW.F) may have filed for bankruptcy (again) last week, but rival AMC Entertainment (NYSE: AMC) isn't in the same dire straits. That's the word from AMC's
How Many Stocks Should You Own?
How many stocks should you have in your portfolio? This polarizing question always sparks debate. A simple way to add diversification is with an ETF such as the Vanguard S&P 500 ETF (NYSEMKT: VOO)
Is a Mega-Merger Between Tilray and SNDL Inevitable?
Consolidation in the cannabis industry is inevitable. Many businesses are struggling to grow, and pooling resources together can be the best way to increase market share and generate efficiencies.
Your Portfolio Could Be Missing This Stock With Monster Potential
The broader market has been stumbling for most of 2022, though it didn't officially find the sleeping bear's den until June. Now we find ourselves in September -- historically the worst-performing
3 Stocks to Avoid This Week
The market finally bounced back after three rough weeks, but the same could also be said about the three investments I identified in my "three stocks to avoid" column last week. The three stocks I
2023's Massive Social Security COLA Increase May Not Be Enough for Retirees
If you're a Social Security recipient, you probably already know the good news.
Social Security checks are about to jump faster than they have in 40 years. That's because Social Security benefits
Got $3,000? These Stocks Could Double Your Money by 2030
The 24% year-to-date drop in the Nasdaq Composite has tested the patience of investors, but it helps to look at the decline from a different perspective. Even after the recent drop, the Nasdaq is
Is Johnson Controls Stock a Buy?
There's little doubt that stock in building products company Johnson Controls (NYSE: JCI) looks like a good value. But can investors have confidence in a management that disappointed investors in
79% of These Wall Street Analysts Recommend Buying This Monster Growth Stock
The U.S. is in the throes of an economic slowdown as inflation soars and interest rates tick higher, squeezing the spending power of consumers. It's a challenging time for the corporate sector, but
3 Stocks Expecting Good News From the FDA
Good news from the Food and Drug Administration (FDA) can send biotech stocks into the stratosphere. And bad news can bring their share prices crashing down. Our Foolish trio is optimistic about
If I Could Buy Only 1 Stock, This Would Be It
A healthy investment portfolio should hold many different stocks for a long time. Here at the Motley Fool, we recommend selecting 25-30 high-quality stocks and letting them grow for at least five
How Ferrari Stock Leaves Other Automakers in the Dust
Years ago, one of my coworkers quipped to me that the automotive industry was where capital went to die. To some degree, that's fair, as the industry is extremely competitive and capital intensive
Getting a Part-Time Job in Retirement? Beware This Pitfall
Inflation has been soaring this year. And while that's definitely had an impact on working families, it's perhaps had an even more drastic impact on retirees.
Many retirees live on a fixed income
This 1 Number Could Completely Change Your Opinion of Moderna
Moderna (NASDAQ: MRNA) exploded onto the scene when it began development of its coronavirus vaccine. The company had been around for a decade -- but this new mission attracted all eyes. Success of
5 Things to Know About the Porsche IPO
Volkswagen AG (OTC: VWAGY) recently said that it's moving forward with its plans to take its Porsche brand public through an initial public offering (IPO).
It's not every day that a car company
2 Dividend Aristocrats to Buy for Passive Income That Could Outperform the Market
We've all heard that you shouldn't judge a book by its cover, but income-seeking investors sometimes forget this lesson when it comes to picking stocks. Dividend Aristocrats are stocks in the S&P
Is This EV and Tech Industry Supplier the Next Megagrowth Stock?
As demand for electric vehicles (EVs) and semiconductors soars, many investors are focused on lithium mining stocks to help meet the needs of the tech industry. But lithium isn't the only elemental
Should You Buy Carnival Before It Rallies?
Carnival (NYSE: CCL) (NYSE: CUK) experienced its very worst time when the pandemic forced its ships to shore. This period crushed revenue and pushed costs and debt higher. The world's biggest cruise


